Pacific Biosciences Of Stock Technical Analysis

PACB Stock  USD 1.46  0.06  4.29%   
As of the 19th of April, Pacific Biosciences holds the Variance of 61.53, risk adjusted performance of (0.13), and Coefficient Of Variation of (432.96). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pacific Biosciences, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to break down thirteen technical drivers for Pacific Biosciences, which can be compared to its competitors. Please check Pacific Biosciences standard deviation, maximum drawdown, kurtosis, as well as the relationship between the information ratio and potential upside to decide if Pacific Biosciences is priced some-what accurately, providing market reflects its current price of 1.46 per share. Please also confirm Pacific Biosciences jensen alpha, which is currently at (2.17) to check out the company can sustain itself at a future point.

Pacific Biosciences Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Pacific, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Pacific
  
Pacific Biosciences' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Pacific Biosciences Analyst Consensus

Target PriceAdvice# of Analysts
13.77Buy12Odds
Pacific Biosciences of current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Pacific analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Pacific stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Pacific Biosciences, talking to its executives and customers, or listening to Pacific conference calls.
Pacific Analyst Advice Details
Pacific Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Pacific Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Pacific Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Pacific Biosciences Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Pacific Biosciences volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Pacific Biosciences Trend Analysis

Use this graph to draw trend lines for Pacific Biosciences of. You can use it to identify possible trend reversals for Pacific Biosciences as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Pacific Biosciences price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Pacific Biosciences Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Pacific Biosciences of applied against its price change over selected period. The best fit line has a slop of   0.09  , which may suggest that Pacific Biosciences of market price will keep on failing further. It has 122 observation points and a regression sum of squares at 279.27, which is the sum of squared deviations for the predicted Pacific Biosciences price change compared to its average price change.

About Pacific Biosciences Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Pacific Biosciences of on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Pacific Biosciences of based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Pacific Biosciences price pattern first instead of the macroeconomic environment surrounding Pacific Biosciences. By analyzing Pacific Biosciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Pacific Biosciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Pacific Biosciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2021 2022 2023 2024 (projected)
Payables Turnover6.516.5910.636.38
Days Of Inventory On Hand125.31231.98129.15157.86

Pacific Biosciences April 19, 2024 Technical Indicators

Most technical analysis of Pacific help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Pacific from various momentum indicators to cycle indicators. When you analyze Pacific charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
When determining whether Pacific Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacific Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacific Biosciences Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacific Biosciences Of Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacific Biosciences of. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Pacific Biosciences information on this page should be used as a complementary analysis to other Pacific Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Pacific Stock analysis

When running Pacific Biosciences' price analysis, check to measure Pacific Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacific Biosciences is operating at the current time. Most of Pacific Biosciences' value examination focuses on studying past and present price action to predict the probability of Pacific Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacific Biosciences' price. Additionally, you may evaluate how the addition of Pacific Biosciences to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Fundamental Analysis
View fundamental data based on most recent published financial statements
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Is Pacific Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. If investors know Pacific will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacific Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.21)
Revenue Per Share
0.791
Quarterly Revenue Growth
1.133
Return On Assets
(0.11)
Return On Equity
(0.49)
The market value of Pacific Biosciences is measured differently than its book value, which is the value of Pacific that is recorded on the company's balance sheet. Investors also form their own opinion of Pacific Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pacific Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacific Biosciences' market value can be influenced by many factors that don't directly affect Pacific Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacific Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacific Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacific Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.